bpc-157 clinical trial recruiting The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity Multifunctionality and Possible Medical Application
Description
In a Review, Faubert et al
The Phase 2 trial protocol specified that missed doses should not be doubled on the next injection day
National Natural Science Foundation of China (31970913 and 32170957)
Nutrition and Metabolism (Lond)
